A new study offers insights into the relative efficacy of various treatments for alopecia areata (AA), suggesting that ...

Due to the broad landscape of treatments for alopecia areata, we wanted to know the potential benefits and harms of the available treatments and to see if some of them work better than others. What ...

Sun Pharmaceutical Industries, announced its release of Leqselvi in the U.S. earlier this week. Leqselvi™ is currently ...

Sun Pharmaceutical Industries Limited announced Leqselvi (deuruxolitinib) 8 mg tablets is now available to healthcare providers and people living with severe alopecia areata in the US. Leqselvi is ...

The delay in Sun Pharma's launch of Leqselvi in the US was caused by a patent infringement case, which was later settled in a ...

As part of the agreement, Incyte has granted Sun Pharma a limited, non-exclusive license to US Patent Nos. 9,662,335 and ...

Mumbai: Sun Pharmaceutical Industries Limited has announced the launch of LEQSELVI (deuruxolitinib) 8 mg tablets in the U.S.

LEQSELVI now available for prescription in U.S. nationwide, offering a new option for eligible patients MUMBAI, India and ...